Novel pleuromutilins for the oral and intravenous treatment of community and hospital-associated methicillin-resistant Staphyococcus aureus (MRSA) infections (360G-Wellcome-087691_Z_08_A)

£1,085,180

Do not Publish

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 1085180
Applicant Surname Payne
Approval Committee Seeding Drug Discovery Committee
Award Date 2010-03-29T00:00:00+00:00
Financial Year 2009/10
Grant Programme: Title Seeding Drug Discovery Award
Internal ID 087691/Z/08/A
Lead Applicant Dr David Payne
Partnership Value 1085180
Planned Dates: End Date 2012-03-31T00:00:00+00:00
Planned Dates: Start Date 2009-02-01T00:00:00+00:00
Recipient Org: Country United States
Region International